Primary Source NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill April 13, 1997
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Judge Rules First Amendment Protects Distribution Of Off-Label Use Information August 14, 1998
TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
